{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:22:12Z","timestamp":1768274532401,"version":"3.49.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The number of patients with heart failure (HF) is increasing with aging in our society worldwide. Patients with HF who are resistant to medication and device therapy are candidates for heart transplantation (HT). However, the shortage of donor hearts is a serious issue. As an alternative to HT, cardiac regenerative therapy using human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, is expected to be realized. Differentiation of hPSCs into cardiomyocytes (CMs) is facilitated by mimicking normal heart development. To prevent tumorigenesis after transplantation, it is important to eliminate non-CMs, including residual hPSCs, and select only CMs. Among many CM selection systems, metabolic selection based on the differences in metabolism between CMs and non-CMs is favorable in terms of cost and efficacy. Large-scale culture systems have been developed because a large number of hPSC-derived CMs (hPSC-CMs) are required for transplantation in clinical settings. In large animal models, hPSC-CMs transplanted into the myocardium improved cardiac function in a myocardial infarction model. Although post-transplantation arrhythmia and immune rejection remain problems, their mechanisms and solutions are under investigation. In this manner, the problems of cardiac regenerative therapy are being solved individually. Thus, cardiac regenerative therapy with hPSC-CMs is expected to become a safe and effective treatment for HF in the near future. In this review, we describe previous studies related to hPSC-CMs and discuss the future perspectives of cardiac regenerative therapy using hPSC-CMs.<\/jats:p>","DOI":"10.3389\/fcvm.2021.774389","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:03:27Z","timestamp":1638939807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells"],"prefix":"10.3389","volume":"8","author":[{"given":"Yusuke","family":"Soma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuika","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.11386\/jst.55.3_261","article-title":"The Registry Report of Japanese Heart Transplantation-2020","volume":"55","year":"2020","journal-title":"Ishoku"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science."},{"key":"B3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2006.02.002","article-title":"Regeneration gaps: observations on stem cells and cardiac repair","volume":"47","author":"Murry","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1073\/pnas.0935626100","article-title":"A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis","volume":"100","author":"Nakamura","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/dbio.1998.9094","article-title":"Regulation of avian cardiac myogenesis by activin\/TGFbeta and bone morphogenetic proteins","volume":"204","author":"Ladd","year":"1998","journal-title":"Dev Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"19812","DOI":"10.1073\/pnas.0605768103","article-title":"Developmental stage-specific biphasic roles of Wnt\/beta-catenin signaling in cardiomyogenesis and hematopoiesis","volume":"103","author":"Naito","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.1073\/pnas.0702859104","article-title":"Biphasic role for Wnt\/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells","volume":"104","author":"Ueno","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","article-title":"Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies","volume":"2","author":"Hentze","year":"2009","journal-title":"Stem Cell Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12015-009-9054-4","article-title":"Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS)","volume":"5","author":"Fong","year":"2009","journal-title":"Stem Cell Rev Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nbt.1947","article-title":"An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells","volume":"29","author":"Tang","year":"2011","journal-title":"Nat Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/cr.2011.148","article-title":"Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis","volume":"21","author":"Wang","year":"2011","journal-title":"Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nbt.2005","article-title":"SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells","volume":"29","author":"Dubois","year":"2011","journal-title":"Nat Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nmeth.1403","article-title":"Nongenetic method for purifying stem cell-derived cardiomyocytes","volume":"7","author":"Hattori","year":"2010","journal-title":"Nat Methods."},{"key":"B18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.chembiol.2017.04.010","article-title":"Efficient, selective removal of human pluripotent stem cells via ecto-alkaline phosphatase-mediated aggregation of synthetic peptides","volume":"24","author":"Kuang","year":"2017","journal-title":"Cell Chem Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E3281","DOI":"10.1073\/pnas.1303669110","article-title":"Inhibition of pluripotent stem cell-derived teratoma formation by small molecules","volume":"110","author":"Lee","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.stemcr.2015.02.016","article-title":"Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein","volume":"4","author":"Tateno","year":"2015","journal-title":"Stem Cell Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1038\/ncomms2992","article-title":"Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells","volume":"4","author":"Ben-David","year":"2013","journal-title":"Nat Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cmet.2016.03.001","article-title":"Glutamine oxidation is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tohyama","year":"2016","journal-title":"Cell Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cmet.2014.03.017","article-title":"Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells","volume":"19","author":"Shiraki","year":"2014","journal-title":"Cell Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.stem.2012.11.015","article-title":"Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen","volume":"12","author":"Ben-David","year":"2013","journal-title":"Cell Stem Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"101535","DOI":"10.1016\/j.isci.2020.101535","article-title":"Fatty acid synthesis is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tanosaki","year":"2020","journal-title":"iScience."},{"key":"B27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.bbrc.2019.02.094","article-title":"Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3","volume":"511","author":"Okada","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"32532","DOI":"10.1038\/srep32532","article-title":"MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells","volume":"6","author":"Parr","year":"2016","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","article-title":"Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.stemcr.2014.09.017","article-title":"Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture","volume":"3","author":"Kempf","year":"2014","journal-title":"Stem Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.5966\/sctm.2014-0275","article-title":"A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells","volume":"4","author":"Fonoudi","year":"2015","journal-title":"Stem Cells Transl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stemcr.2019.06.004","article-title":"Continuous WNT control enables advanced hPSC cardiac processing and prognostic surface marker identification in chemically defined suspension culture","volume":"13","author":"Halloin","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.scr.2014.06.002","article-title":"An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures","volume":"13","author":"Ting","year":"2014","journal-title":"Stem Cell Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.scr.2018.07.020","article-title":"Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess","volume":"31","author":"Ting","year":"2018","journal-title":"Stem Cell Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","article-title":"Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes","volume":"9","author":"Tohyama","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0230001","DOI":"10.1371\/journal.pone.0230001","article-title":"Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques","volume":"15","author":"Rupert","year":"2020","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1161\/CIRCRESAHA.116.310328","article-title":"Safe and effective cardiac regenerative therapy with human-induced pluripotent stem cells: how should we prepare pure cardiac myocytes?","volume":"120","author":"Tohyama","year":"2017","journal-title":"Circ Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","article-title":"Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation","volume":"56","author":"Lopaschuk","year":"2010","journal-title":"J Cardiovasc Pharmacol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"32361","DOI":"10.1038\/srep32361","article-title":"Visualization of in vivo metabolic flows reveals accelerated utilization of glucose and lactate in penumbra of ischemic heart","volume":"6","author":"Sugiura","year":"2016","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/01.RES.67.1.23","article-title":"Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats","volume":"67","author":"Olivetti","year":"1990","journal-title":"Circ Res."},{"key":"B41","first-page":"I141","article-title":"The relationship of myocardial infarct size and prognosis","volume":"53","author":"Caulfield","year":"1976","journal-title":"Circulation."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.5966\/sctm.2014-0072","article-title":"A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Hemmi","year":"2014","journal-title":"Stem Cells Transl Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2008.07.111","article-title":"Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells","volume":"375","author":"Miyazaki","year":"2008","journal-title":"Biochem Biophys Res Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat Methods."},{"key":"B45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nmeth.1532","article-title":"A defined glycosaminoglycan-binding substratum for human pluripotent stem cells","volume":"7","author":"Klim","year":"2010","journal-title":"Nat Methods."},{"key":"B46","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nbt.1629","article-title":"Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells","volume":"28","author":"Melkoumian","year":"2010","journal-title":"Nat Biotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.isci.2021.102090","article-title":"Tryptophan metabolism regulates proliferative capacity of human pluripotent stem cells","volume":"24","author":"Someya","year":"2021","journal-title":"iScience."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0131446","DOI":"10.1371\/journal.pone.0131446","article-title":"Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts","volume":"10","author":"Gerbin","year":"2015","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3727\/096368914X685799","article-title":"Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart","volume":"24","author":"Higuchi","year":"2015","journal-title":"Cell Transplant."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.stemcr.2017.09.007","article-title":"Human pluripotent stem cell-derived cardiac tissue-like constructs for repairing the infarcted myocardium","volume":"9","author":"Li","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci Transl Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.120.047904","article-title":"Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner","volume":"143","author":"Querdel","year":"2021","journal-title":"Circulation."},{"key":"B54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.healun.2021.04.010","article-title":"Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model","volume":"40","author":"Suzuki","year":"2021","journal-title":"J Heart Lung Transplant."},{"key":"B55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature."},{"key":"B56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature."},{"key":"B57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jacbts.2020.11.017","article-title":"Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"JACC Basic Transl Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.celrep.2016.12.040","article-title":"Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy","volume":"18","author":"Cho","year":"2017","journal-title":"Cell Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.stemcr.2016.10.009","article-title":"In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts","volume":"8","author":"Kadota","year":"2017","journal-title":"Stem Cell Reports."},{"key":"B62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cardiores.2004.10.004","article-title":"Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice","volume":"65","author":"Hattan","year":"2005","journal-title":"Cardiovasc Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0133308","DOI":"10.1371\/journal.pone.0133308","article-title":"Gelatin hydrogel enhances the engraftment of transplanted cardiomyocytes and angiogenesis to ameliorate cardiac function after myocardial infarction","volume":"10","author":"Nakajima","year":"2015","journal-title":"PLoS ONE."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41551-018-0191-4","article-title":"Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix","volume":"2","author":"Lee","year":"2018","journal-title":"Nat Biomed Eng."},{"key":"B66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-019-11091-2","article-title":"Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41587-019-0197-9","article-title":"Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration","volume":"37","author":"Bargehr","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"eaax2992","DOI":"10.1126\/scitranslmed.aax2992","article-title":"Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats","volume":"12","author":"Sun","year":"2020","journal-title":"Sci Transl Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1038\/s41467-021-23329-z","article-title":"Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells","volume":"12","author":"Funakoshi","year":"2021","journal-title":"Nat Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Reports"},{"key":"B74","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","article-title":"Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine","volume":"17","author":"Karbassi","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s12015-013-9457-0","article-title":"Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin","volume":"9","author":"Lu","year":"2013","journal-title":"Stem Cell Rev Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasch\u00e9","year":"2015","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.774389\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T05:03:31Z","timestamp":1638939811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.774389\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":78,"alternative-id":["10.3389\/fcvm.2021.774389"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.774389","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"article-number":"774389"}}